Unknown OBSERVATIONAL NCT03142412

Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization (LIFT)

Sponsor: DxTerity Diagnostics

Conditions Lupus Lupus Erythematosus Lupus Erythematosus, Systemic Systemic Lupus Erythematosus

Updated 8 times since 2017 Last updated: Jun 26, 2018 Started: Apr 17, 2017 Primary completion: Oct 17, 2021 Completion: Oct 17, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03142412, this observational or N/A phase trial focuses on Lupus and Lupus Erythematosus and remains ongoing. Sponsored by DxTerity Diagnostics, it has been updated 8 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Mar 2022 — Jul 2024 [monthly]

Unknown Status

Status: Active Not Recruiting → Unknown Status
Jan 2021 — Mar 2022 [monthly]

Active Not Recruiting
Jul 2018 — Jan 2021 [monthly]

Active Not Recruiting

Status: Recruiting → Active Not Recruiting

▶ Show 3 earlier versions

Jun 2018 — Jul 2018 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Jun 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Apr 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

DxTerity Diagnostics

Data source: DxTerity Diagnostics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Compton, United States